Even though EAT physiologically produces anti-inflammatory cytokines such as adiponectin and provides antiatherogenic and cardioprotective effects, in pathological conditions, it may produce proinflammatory cytokines and promote the development of coronary artery disease (CAD) [12, 13], as in the case of obesity and its metabolic consequences [10, 11]. Here, ADIPOQ is linked to coronary artery disorder.